Oxford Gene Technology (OGT) and Integrated Genomics (IG) have announced the signing of a collaboration to develop and market a Pichia pastoris Gene Expression (GE) oligonucleotide microarray.
The collaboration gives OGT access to IG’s proprietary Pichia pastoris genomic sequence for the design and development of a high quality optimised 60 mer oligonucleotide microarray using the ink jet in-situ synthesis (IJISS) platform. OGT will market the array worldwide, and offer a sample analysis service at its Oxford laboratory.
Mr James Clough, Commercial Director at OGT said: “We are delighted to be working with Integrated Genomics. The combination of OGT’s oligonucleotide array expertise combined with Integrated Genomics sequence and detailed Pichia genome annotations will be a powerful molecular research tool for the Pichia community and add strength to our growing portfolio.”
Dr Theresa Walunas, Vice President of Integrated Genomics added: “OGT’s IJISS technology provides an important new capability to the Pichia research community. Microarrays will allow researchers to understand how Pichia’s gene expression changes in response to genetic modifications.”